Literature DB >> 20956399

Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome.

M Khalil1, C Enzinger, C Langkammer, K Petrovic, M Loitfelder, M Tscherner, M Jehna, G Bachmaier, M Wallner-Blazek, S Ropele, R Schmidt, S Fuchs, F Fazekas.   

Abstract

BACKGROUND: Cognitive deficits are frequent in multiple sclerosis (MS) and have been associated with morphologic brain changes. Less information exists on their extent and relation to MRI findings in clinically isolated syndrome (CIS). It is also unclear if structural changes as detected by magnetization transfer (MT) imaging may provide an additional explanation for cognitive dysfunction.
OBJECTIVE: To analyse the extent of cognitive deficits and their relation to MRI metrics including MT imaging in CIS compared to relapsing-remitting MS (RRMS).
METHODS: Forty-four CIS and 80 RRMS patients underwent the Brief Repeatable Battery of Neuropsychological Tests (BRB-N) and a 3 T MRI scan.
RESULTS: BRB-N subtests revealed similar results in CIS and RRMS. Impaired mental processing speed was most prevalent in both groups (CIS 13.6%; RRMS 16.3%) and thus served for correlation with MRI metrics. Using stepwise linear regression analyses, the strongest predictor for decreased mental processing speed was normalized cortex volume (p < 0.001) followed by T₂-lesion load (p < 0.05) in RRMS, whereas cortical MT ratio was the only MRI parameter associated with decreased mental processing speed in CIS (p < 0.005).
CONCLUSION: Cognitive dysfunction occurs in CIS in a pattern similar to RRMS, with impaired mental processing speed being most prevalent. Cortical MT-ratio changes may be an early sign for tissue changes related to impaired mental processing speed in CIS while this association shifts to increased signs of cortical atrophy and lesion load in RRMS.

Entities:  

Mesh:

Year:  2010        PMID: 20956399     DOI: 10.1177/1352458510384009

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  20 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010.

Authors:  Stuart D Cook; Suhayl Dhib-Jalbut; Peter Dowling; Luca Durelli; Corey Ford; Gavin Giovannoni; June Halper; Colleen Harris; Joseph Herbert; David Li; John A Lincoln; Robert Lisak; Fred D Lublin; Claudia F Lucchinetti; Wayne Moore; Robert T Naismith; Carlos Oehninger; Jack Simon; Maria Pia Sormani
Journal:  Int J MS Care       Date:  2012

3.  Cognitive impairment and MS: searching for effective therapies.

Authors:  Vijayshree Yadav; Dennis N Bourdette
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

4.  Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis.

Authors:  Eva Hynčicová; Martin Vyhnálek; Adam Kalina; Lukáš Martinkovič; Tomáš Nikolai; Jiří Lisý; Jakub Hort; Eva Meluzínová; Jan Laczó
Journal:  J Neurol       Date:  2016-12-27       Impact factor: 4.849

5.  Extensive white matter dysfunction in cognitively impaired patients with secondary-progressive multiple sclerosis.

Authors:  P L Francis; T L Chia; R Jakubovic; P O'Connor; L Lee; A Feinstein; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-15       Impact factor: 3.825

Review 6.  The prognostic utility of MRI in clinically isolated syndrome: a literature review.

Authors:  C Odenthal; A Coulthard
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-15       Impact factor: 3.825

Review 7.  Correlations between MRI and Information Processing Speed in MS: A Meta-Analysis.

Authors:  S M Rao; A L Martin; R Huelin; E Wissinger; Z Khankhel; E Kim; K Fahrbach
Journal:  Mult Scler Int       Date:  2014-03-25

8.  CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.

Authors:  M Khalil; C Enzinger; C Langkammer; S Ropele; A Mader; A Trentini; M L G Vane; M Wallner-Blazek; G Bachmaier; J-J Archelos; M J A Koel-Simmelink; M A Blankenstein; S Fuchs; F Fazekas; C E Teunissen
Journal:  Mult Scler       Date:  2012-08-23       Impact factor: 6.312

9.  Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study.

Authors:  J H Faiss; D Dähne; K Baum; R Deppe; F Hoffmann; W Köhler; A Kunkel; A Lux; M Matzke; I K Penner; M Sailer; U K Zettl
Journal:  BMJ Open       Date:  2014-04-10       Impact factor: 2.692

Review 10.  Gray matters in multiple sclerosis: cognitive impairment and structural MRI.

Authors:  Silvia Messina; Francesco Patti
Journal:  Mult Scler Int       Date:  2014-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.